# Imunon, Inc.: filings

IMNN · Nasdaq · CIK 749647 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imnn.md) · [Financials](/companies/imnn/financials.md) · [Filings](/companies/imnn/filings.md) · [Insiders](/companies/imnn/insiders.md)

## Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 463, 8-K 252, 10-Q 53, 424B5 36, CORRESP 29, SC 13G/A 25, EFFECT 24, S-1/A 22, UPLOAD 22, 3 21, SC 13G 21, 424B3 20, DEF 14A 19, 10-K 18, S-1 15, S-3 13, S-8 11, PRE 14A 8, CT ORDER 6, D 6, ARS 5, DEFA14A 5, S-3/A 5, SCHEDULE 13G/A 5, 4/A 4, RW 4, 10-K/A 3, 8-K/A 3, SC 13D/A 3, 10-Q/A 2, DRS 2, SC 13D 2, SCHEDULE 13G 2, 424B4 1, FWP 1, POS AM 1, PRER14A 1, S-3MEF 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 06:15 ET | [S-1](/filings/0001493152-26-048630.md) | Registration statement | 0001493152-26-048630 |
| 2026-10-27 | 06:05 ET | [8-K](/filings/0001493152-26-048625.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-048625 |
| 2026-10-21 | 08:15 ET | [8-K](/filings/0001493152-26-047850.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047850 |
| 2026-09-29 | 08:00 ET | [8-K](/filings/0001493152-26-044792.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-044792 |
| 2026-08-11 | 17:00 ET | [8-K](/filings/0001493152-26-037170.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-037170 |
| 2026-08-11 | 08:30 ET | [10-Q](/filings/0001493152-26-036991.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036991 |
| 2026-08-11 | 08:01 ET | [8-K](/filings/0001493152-26-036985.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036985 |
| 2026-06-30 | 16:30 ET | [8-K](/filings/0001493152-26-031292.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031292 |
| 2026-06-16 | 17:30 ET | [8-K](/filings/0001493152-26-028937.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-028937 |
| 2026-06-04 | 08:00 ET | [8-K](/filings/0001493152-26-027201.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027201 |
| 2026-05-12 | 08:45 ET | [10-Q](/filings/0001493152-26-022416.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022416 |
| 2026-05-12 | 08:05 ET | [8-K](/filings/0001493152-26-022401.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022401 |
| 2026-05-04 | 08:00 ET | [8-K](/filings/0001493152-26-021019.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-021019 |
| 2026-05-04 | 06:31 ET | [DEF 14A](/filings/0001493152-26-020999.md) | Proxy statement, period 2026-05-04 | 0001493152-26-020999 |
| 2026-03-31 | 08:50 ET | [10-K](/filings/0001493152-26-013850.md) | Annual report, period 2025-12-31 | 0001493152-26-013850 |
| 2026-03-31 | 08:05 ET | [8-K](/filings/0001493152-26-013816.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013816 |
| 2026-03-23 | 16:16 ET | [8-K](/filings/0001493152-26-012164.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012164 |
| 2026-02-05 | 08:05 ET | [8-K](/filings/0001493152-26-005203.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-005203 |
| 2026-01-07 | 17:15 ET | [8-K](/filings/0001493152-26-000841.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-000841 |
| 2025-12-31 | 08:00 ET | [8-K](/filings/0001493152-25-029711.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029711 |
| 2025-11-13 | 07:55 ET | [10-Q](/filings/0001493152-25-022120.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022120 |
| 2025-11-13 | 07:48 ET | [8-K](/filings/0001493152-25-022118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022118 |
| 2025-08-28 | 08:08 ET | [8-K](/filings/0001493152-25-012417.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-012417 |
| 2025-08-05 | 09:00 ET | [10-Q](/filings/0001493152-25-011598.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011598 |
| 2025-08-05 | 08:03 ET | [8-K](/filings/0001493152-25-011597.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011597 |
| 2025-07-28 | 08:10 ET | [8-K](/filings/0001493152-25-011440.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011440 |
| 2025-07-23 | 08:02 ET | [8-K](/filings/0001641172-25-020652.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020652 |
| 2025-07-22 | 08:05 ET | [8-K](/filings/0001641172-25-020520.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020520 |
| 2025-07-14 | 17:12 ET | [8-K](/filings/0001641172-25-019541.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001641172-25-019541 |
| 2025-07-11 | 17:00 ET | [8-K](/filings/0001641172-25-018797.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-018797 |
| 2025-06-13 | 17:15 ET | [8-K](/filings/0001641172-25-015124.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-015124 |
| 2025-06-09 | 16:30 ET | [DEF 14A](/filings/0001641172-25-014324.md) | Proxy statement, period 2025-06-09 | 0001641172-25-014324 |
| 2025-06-09 | 14:35 ET | [8-K](/filings/0001641172-25-014279.md) | 8.01 Other events | 0001641172-25-014279 |
| 2025-05-30 | 17:03 ET | [S-1](/filings/0001641172-25-013088.md) | Registration statement | 0001641172-25-013088 |
| 2025-05-30 | 16:30 ET | [8-K](/filings/0001641172-25-013051.md) | 3.01 Delisting notice | 0001641172-25-013051 |
| 2025-05-27 | 07:30 ET | [8-K](/filings/0001641172-25-012395.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-012395 |
| 2025-05-22 | 09:27 ET | [8-K](/filings/0001641172-25-011999.md) | 8.01 Other events | 0001641172-25-011999 |
| 2025-05-20 | 07:00 ET | [8-K](/filings/0001641172-25-011601.md) | 3.01 Delisting notice | 0001641172-25-011601 |
| 2025-05-19 | 08:20 ET | [S-1/A](/filings/0001641172-25-011388.md) | Registration statement, amended | 0001641172-25-011388 |
| 2025-05-13 | 06:10 ET | [S-1/A](/filings/0001641172-25-009814.md) | Registration statement, amended | 0001641172-25-009814 |
| 2025-05-13 | 19:29 ET | [8-K](/filings/0001641172-25-009775.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009775 |
| 2025-05-12 | 08:15 ET | [10-Q](/filings/0001641172-25-009572.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009572 |
| 2025-05-12 | 08:05 ET | [8-K](/filings/0001641172-25-009570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009570 |
| 2025-04-04 | 17:29 ET | [S-1](/filings/0001641172-25-002783.md) | Registration statement | 0001641172-25-002783 |
| 2025-03-24 | 08:05 ET | [8-K](/filings/0001641172-25-000207.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000207 |
| 2025-02-27 | 08:15 ET | [10-K](/filings/0001493152-25-008460.md) | Annual report, period 2024-12-31 | 0001493152-25-008460 |
| 2025-02-27 | 08:10 ET | [8-K](/filings/0001493152-25-008457.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-008457 |
| 2025-02-10 | 08:10 ET | [8-K](/filings/0001493152-25-005536.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005536 |
| 2024-11-27 | 16:30 ET | [8-K](/filings/0001493152-24-048008.md) | 3.01 Delisting notice | 0001493152-24-048008 |
| 2024-11-07 | 09:05 ET | [8-K](/filings/0001493152-24-043933.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-043933 |

Page 1 of 8. [Older](/companies/imnn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:17 ET. No prices; not investment advice.